About Diagnostic Ansers
Diagnostic Ansers is a company based in Washington (United States) founded in 2012. Diagnostic Ansers operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Biological Dynamics, among others.
- Headquarter Washington, United States
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$5 K (USD), Grant
Jun 01, 2016
-
Investors
Jenoptik
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Diagnostic Ansers
Investors in Diagnostic Ansers
Diagnostic Ansers has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Jenoptik and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of products and services for photonics market
|
Locked | Locked | Locked | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked |
Investor details for Diagnostic Ansers
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Diagnostic Ansers
Investment portfolio details for Diagnostic Ansers
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Diagnostic Ansers
Detailed financials for Diagnostic Ansers
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Diagnostic Ansers Comparisons
Peer comparison for Diagnostic Ansers
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Diagnostic Ansers
Diagnostic Ansers operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Biological Dynamics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Proprietary lab-on-chip platform for nanoparticle isolation is offered.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
Detailed competitors of Diagnostic Ansers
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Diagnostic Ansers
Complete news archive for Diagnostic Ansers
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Diagnostic Ansers
Diagnostic Ansers was founded in 2012 and raised its 1st funding round 3 years after it was founded.
Diagnostic Ansers is headquartered in Washington, United States. It is registered at Washington, District Of Columbia, United States.
Diagnostic Ansers was founded in 2012 and focuses on the diagnostics and trace chemical detection sector. Ink-jet printed surface enhanced Raman spectroscopy (SERS)-active substrates are developed and marketed for these applications. Surface plasmon resonant spherical gold and silver nanoparticles are provided as bases for SERS measurements. Sensors are employed in swab and dipstick formats to identify traces of explosives, narcotics, and contaminants.
Diagnostic Ansers's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Diagnostic Ansers has 2 investors. Key investors include Jenoptik, and National Science Foundation.